Farther Finance Advisors, LLC Genenta Science S.P.A. Transaction History
Farther Finance Advisors, LLC
- $9.33 Trillion
- Q4 2025
A detailed history of Farther Finance Advisors, LLC transactions in Genenta Science S.P.A. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 3 shares of GNTA stock, worth $6. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$6% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GNTA
# of Institutions
9Shares Held
555KCall Options Held
0Put Options Held
0-
Allianz Se Munich, 2M234KShares$514,9100.02% of portfolio
-
Al Ti Global, Inc. New York, NY200KShares$440,6330.01% of portfolio
-
Algebris (Uk) LTD London, X0100KShares$220,0000.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.5KShares$27,4690.0% of portfolio
-
Ubs Group Ag3.42KShares$7,5150.0% of portfolio
About Genenta Science S.p.A.
- Ticker GNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,216,900
- Market Cap $40.1M
- Description
- Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated...